The National Academies Press

Currently Skimming:

Pages 583-585

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 583... ... Presentation of the Charge to the Institute of Medicine Committee Mitch Zeller, Food and Drug Administration (current affiliation, American Legacy Foundation Bern Schwetz, Food and Drug Administration March 2, 2000, Washington, D.C. Harm Reduction and Lessons Learned: Historical Perspective and Policy Advice John Slade, University of Medicine and Dentistry at New Jersey School of Public Health Harm Reduction and Lessons Learned: Low Tar and Nicotine Story Don Shopland, National Cancer Institute Tobacco Toxicology Review: Emphasis on Carcinogenesis Steve Hecht, University of Minnesota Exposure Assays David Ashley, Centers for Disease Control and Prevention Nicotine Pharmacology and Toxicology Neal Benowitz, University of California, San Francisco 583 Read the entire page →
From page 584... ... 584 April 25, 2000, Washington, D.C. Risk Perception and Decision Making Paul Slovic, Decision Research, University of Oregon Epidemiology of Low-Tar Cigarettes David Burns, University of California, San Diego Clinical Trial Design Considerations rack Henningfield, Pinney Associates, Johns Hopkins School of Medicine Canine Pillitteri, Pinney Associates John Hughes, University of Vermont Clinical Indicators of Chronic Obstructive Pulmonary Disease Steve Rennard, University of Nebraska Physical and Chemical Characteristics of Tobacco Smoke Robert Phalen, University of California, Irvine State of Massachusetts Regulation of Tobacco Products Gregory Connolly, Massachusetts Department of Public Health Michael Borgerding, R.r. Read the entire page →
From page 585... ... Swauger Star Scientific, Inc. Scott D Read the entire page →

From page 583...

... Presentation of the Charge to the Institute of Medicine Committee Mitch Zeller, Food and Drug Administration (current affiliation, American Legacy Foundation Bern Schwetz, Food and Drug Administration March 2, 2000, Washington, D.C. Harm Reduction and Lessons Learned: Historical Perspective and Policy Advice John Slade, University of Medicine and Dentistry at New Jersey School of Public Health Harm Reduction and Lessons Learned: Low Tar and Nicotine Story Don Shopland, National Cancer Institute Tobacco Toxicology Review: Emphasis on Carcinogenesis Steve Hecht, University of Minnesota Exposure Assays David Ashley, Centers for Disease Control and Prevention Nicotine Pharmacology and Toxicology Neal Benowitz, University of California, San Francisco 583

Read the entire page →

From page 584...

... 584 April 25, 2000, Washington, D.C. Risk Perception and Decision Making Paul Slovic, Decision Research, University of Oregon Epidemiology of Low-Tar Cigarettes David Burns, University of California, San Diego Clinical Trial Design Considerations rack Henningfield, Pinney Associates, Johns Hopkins School of Medicine Canine Pillitteri, Pinney Associates John Hughes, University of Vermont Clinical Indicators of Chronic Obstructive Pulmonary Disease Steve Rennard, University of Nebraska Physical and Chemical Characteristics of Tobacco Smoke Robert Phalen, University of California, Irvine State of Massachusetts Regulation of Tobacco Products Gregory Connolly, Massachusetts Department of Public Health Michael Borgerding, R.r.

Read the entire page →

From page 585...

... Swauger Star Scientific, Inc. Scott D

Read the entire page →

Key Terms

cancer inst

star scientific

harm reduction

← Previous Chapter Skim

Next Chapter Skim →

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.